Insulin-like growth factor system gene expression in cervical scrapes from women with squamous intraepithelial lesions and cervical cancer

Growth Hormone and IGF Research

Volumn 17, Issue 6, 2007, Pages 492-499

  Serrano, Martha Lucía ^a,b   Sánchez Gómez, Myriam ^b   Bravo, María Mercedes ^a  

^a Instituto Nacional de Cancerología   (Colombia)

^b Facultad de Ciencias   (Colombia)

Author keywords

Cervical cancer; Insulin like growth factor binding protein 3; Insulin like growth factor I; Insulin like growth factor I receptor; Insulin like growth factor II; mRNA; Papanicolau smear (Pap smear); Squamous intraepithelial lesions (SIL)

Indexed keywords

MESSENGER RNA; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; ARTICLE; CANCER GRADING; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 35848961907     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2007.07.001     Document Type: Article

References (53)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94 (2001) 153-156
2. Walboomers J.M., Jacobs M.V., Manos M.M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
3. Holowaty P., Miller A.B., Rohan T., and To T. Natural history of dysplasia of the uterine cervix. J. Natl. Cancer Inst. 91 (1999) 252-258
4. Woodman C.B., Collins S., Winter H., et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357 (2001) 1831-1836
5. Baserga R., Sell C., Porcu P., and Rubini M. The role of the IGF-I receptor in the growth and transformation of mammalian cells. Cell Prolif. 27 (1994) 63-71
6. Werner H., and LeRoith D. The role of the insulin-like growth factor system in human cancer. Adv. Cancer Res. 68 (1996) 183-223
7. LeRoith D., Werner H., Beitner-Johnson D., and Roberts Jr. C.T. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 16 (1995) 143-163
8. Ricort J.M., and Binoux M. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity. Endocrinology 142 (2001) 108-113
9. Hankinson S.E., Willett W.C., Colditz G.A., et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351 (1998) 1393-1396
10. Chan J.M., Stampfer M.J., Giovannucci E., et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279 (1998) 563-566
11. London S.J., Yuan J.M., Travlos G.S., et al. Insulin-like growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China. J. Natl. Cancer Inst. 94 (2002) 749-754
12. Giovannucci E., Pollak M., Platz E.A., et al. IGF-binding protein-3 and the risk of colorectal adenoma and cancer in the Nurses' Health Study. Growth Horm. IGF. Res. 10 (2000) S30-S31
13. Sell C., Dumenil G., Deveaud C., et al. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell Biol. 14 (1994) 3604-3612
14. Valentinis B., Porcu P.L., Quinn K., and Baserga R. The role of the insulin-like growth factor I receptor in the transformation by simian virus 40 T antigen. Oncogene 9 (1994) 825-831
15. Coppola D., Ferber A., Miura M., et al. A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol. Cell Biol. 14 (1994) 4588-4595
16. Sachdev D., Hartell J.S., Lee A.V., Zhang X., and Yee D. A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells. J. Biol. Chem. 279 (2004) 5017-5024
17. Huff K.K., Kaufman D., Gabbay K.H., Spencer E.M., Lippman M.E., and Dickson R.B. Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Res. 46 (1986) 4613-4619
18. Figueroa J.A., Lee A.V., Jackson J.G., and Yee D. Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (IGF) binding protein-1: evidence for an IGF-II autocrine growth loop. J. Clin. Endocrinol. Metab. 80 (1995) 3476-3482
19. Tennant M.K., Thrasher J.B., Twomey P.A., Drivdahl R.H., Birnbaum R.S., and Plymate S.R. Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium. J. Clin. Endocrinol. Metab. 81 (1996) 3774-3782
20. Yee D., Paik S., Lebovic G.S., et al. Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol. Endocrinol. 3 (1989) 509-517
21. Cullen K.J., Yee D., Sly W.S., et al. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res. 50 (1990) 48-53
22. Hellawell G.O., Turner G.D., Davies D.R., Poulsom R., Brewster S.F., and Macaulay V.M. Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease. Cancer Res. 62 (2002) 2942-2950
23. LeRoith D., and Roberts Jr. C.T. The insulin-like growth factor system and cancer. Cancer Lett. 195 (2003) 127-137
24. Rajah R., Valentinis B., and Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem. 272 (1997) 12181-12188
25. Hassan A.B., and Howell J.A. Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice. Cancer Res. 60 (2000) 1070-1076
26. Lopez T., and Hanahan D. Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. Cancer Cell 1 (2002) 339-353
27. Steller M.A., Delgado C.H., Bartels C.J., Woodworth C.D., and Zou Z. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells. Cancer Res. 56 (1996) 1761-1765
28. Steller M.A., Delgado C.H., and Zou Z. Insulin-like growth factor II mediates epidermal growth factor-induced mitogenesis in cervical cancer cells. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 11970-11974
29. Nakamura K., Hongo A., Kodama J., Miyagi Y., Yoshinouchi M., and Kudo T. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines. Cancer Res. 60 (2000) 760-765
30. Berger A.J., Baege A., Guillemette T., et al. Insulin-like growth factor-binding protein 3 expression increases during immortalization of cervical keratinocytes by human papillomavirus type 16 E6 and E7 proteins. Am. J. Pathol. 161 (2002) 603-610
31. Baege A.C., Disbrow G.L., and Schlegel R. IGFBP-3, a marker of cellular senescence, is overexpressed in human papillomavirus-immortalized cervical cells and enhances IGF-1-induced mitogenesis. J. Virol. 78 (2004) 5720-5727
32. Solomon D., Davey D., Kurman R., et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 287 (2002) 2114-2119
33. J. Vandesompele, K. De Preter, F. Pattyn et al., Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biol., 3 (2002) RESEARCH0034-.
34. Sekyi-Otu A., Bell R.S., Ohashi C., Pollak M., and Andrulis I.L. Insulin-like growth factor 1 (IGF-1) receptors, IGF-1, and IGF-2 are expressed in primary human sarcomas. Cancer Res. 55 (1995) 129-134
35. Pfaffl M.W., Georgieva T.M., Georgiev I.P., Ontsouka E., Hageleit M., and Blum J.W. Real-time RT-PCR quantification of insulin-like growth factor (IGF)-1, IGF-1 receptor, IGF-2, IGF-2 receptor, insulin receptor, growth hormone receptor, IGF-binding proteins 1, 2 and 3 in the bovine species. Domest. Anim Endocrinol. 22 (2002) 91-102
36. Saiki R.K., Scharf S., Faloona F., et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230 (1985) 1350-1354
37. Molano M., Posso H., Weiderpass E., et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br. J. Cancer 87 (2002) 324-333
38. Jacobs M.V., Snijders P.J., van den Brule A.J., Helmerhorst T.J., Meijer C.J., and Walboomers J.M. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J. Clin. Microbiol. 35 (1997) 791-795
39. Cuzick J., Meijer C.J., and Walboomers J.M. Screening for cervical cancer. Lancet 351 (1998) 1439-1440
40. Goldie S.J. Health economics and cervical cancer prevention: a global perspective. Virus Res. 89 (2002) 301-309
41. Buckbinder L., Talbott R., Velasco-Miguel S., et al. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377 (1995) 646-649
42. Papa V., Gliozzo B., Clark G.M., et al. Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res. 53 (1993) 3736-3740
43. Bonneterre J., Peyrat J.P., Beuscart R., and Demaille A. Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer. Cancer Res. 50 (1990) 6931-6935
44. Peyrat J.P., and Bonneterre J. Type 1 IGF receptor in human breast diseases. Breast Cancer Res. Treat. 22 (1992) 59-67
45. Schnarr B., Strunz K., Ohsam J., Benner A., Wacker J., and Mayer D. Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer. Int. J. Cancer 89 (2000) 506-513
46. Voskuil D.W., Bosma A., Vrieling A., Rookus M.A., and 't Veer L.J. Insulin-like growth factor (IGF)-system mRNA quantities in normal and tumor breast tissue of women with sporadic and familial breast cancer risk. Breast Cancer Res. Treat. 84 (2004) 225-233
47. Plymate S.R., Tennant M., Birnbaum R.S., Thrasher J.B., Chatta G., and Ware J.L. The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus-40 T antigen. J. Clin. Endocrinol. Metab. 81 (1996) 3709-3716
48. Pennisi P.A., Barr V., Nunez N.P., Stannard B., and Le Roith D. Reduced expression of insulin-like growth factor I receptors in MCF-7 breast cancer cells leads to a more metastatic phenotype. Cancer Res. 62 (2002) 6529-6537
49. Mauro L., Bartucci M., Morelli C., Ando' S., and Surmacz E. IGF-I receptor-induced cell-cell adhesion of MCF-7 breast cancer cells requires the expression of junction protein ZO-1. J. Biol. Chem. 276 (2001) 39892-39897
50. Nielsen T.O., Andrews H.N., Cheang M., et al. Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin. Cancer Res. 64 (2004) 286-291
51. Cardillo M.R., Monti S., Di Silverio F., Gentile V., Sciarra F., and Toscano V. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer. Anticancer Res. 23 (2003) 3825-3835
52. S. Sperandio, I. De Belle, D.E. Bredesen, An alternative, nonapoptotic form of programmed cell death, Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 14376-14381.
53. Lee A.V., Hilsenbeck S.G., and Yee D. IGF system components as prognostic markers in breast cancer. Breast Cancer Res. Treat. 47 (1998) 295-302